T 0655/24 concerns Genmab’s patent EP2943507 disclosing an antibody with an engineered triple Fc region mutation (L234F/L235E/D265A) – the “FEA”…
Read More
T 0655/24 concerns Genmab’s patent EP2943507 disclosing an antibody with an engineered triple Fc region mutation (L234F/L235E/D265A) – the “FEA”…
Read More
When discussing growth, investment, acquisitions, refinancing or exit strategies with clients, financial advisers routinely explore revenue, profitability, funding and future…
Read More
For many UK businesses developing and selling physical products, China is both an important manufacturing base and a growing sales…
Read More
Further to our previous article, the Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) has just issued…
Read More
Intellectual property (IP) firm Barker Brettell has relocated its Southampton office to Ocean Village Innovation Centre (OVIC), reinforcing the firm’s…
Read More
Over the first half of this year, Abbott Diabetes Care (Abbott) secured two wins at the Unified Patent Court (UPC)…
Read More
Most of us already use artificial intelligence to some extent, writes Lucy Walker, but to understand its impact on the…
Read More
What can we learn from the recent Supreme Court ruling with plant-based brand, Oatly? Chartered Trade Mark Attorney, Craig Beaumont…
Read More
As London prepares to host the International Trademark Association (INTA) annual meeting in 2026 – the world’s largest gathering of…
Read More
‘Copyright’ is an automatic legal right that protects original literary, dramatic, musical and artistic works, films, sound and music recordings,…
Read More
The Enlarged Board of Appeal (EBA) of the European Patent Office (EPO) has now issued its preliminary opinion in G…
Read More
The UK Supreme Court has dismissed Oatly’s appeal concerning its trade mark ‘POST MILK GENERATION’, confirming the mark was invalid…
Read More